HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effect of sequential MTX/5-FU therapy for a case of disseminated intravascular coagulation syndrome associated with recurrence of gastric cancer--a case report].

Abstract
Although a 39-year-old male received the curative operation of total gastrectomy for advanced scirrhous carcinoma of the stomach, recurrence of cancer was occurred soon after the surgery, accompanied by hemorrhagic diathesis from DIC. The abdominal CT scan examination revealed the rapid enlargement in the size of the several lymphnodes around the abdominal aorta, and the blood chemistry tests showed marked increase of the serum CEA value. The sequential chemotherapy with intermediate dose of MTX and 5-FU in conjunction with OK-432 was started to treat the case. This chemotherapy was carried out once a week for 5 times and consequently DIC was led to the perfect remission. Furthermore, CEA level decreased within normal range, and the size of the enlarged lymphnodes at paraaortic area diminished remarkably. Although he complained of nausea and loss of appetite during the treatment, no severe adverse effects such as granulocytopenia, diarrhea, or loss of hair were observed. The successful result in this patient suggests that sequential therapy of intermediate dose of MTX and 5-FU with administration of OK-432 may be effective in the treatment of advanced scirrhous carcinoma of the stomach.
AuthorsH Koike, T Konishi, K Mafune, T Hirata, T Miyama, M Hiraishi, Y Idezuki
JournalNihon Geka Gakkai zasshi (Nihon Geka Gakkai Zasshi) Vol. 90 Issue 7 Pg. 1117-21 (Jul 1989) ISSN: 0301-4894 [Print] Japan
PMID2552283 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Fluorouracil
  • Methotrexate
Topics
  • Adenocarcinoma, Scirrhous (complications, drug therapy)
  • Adult
  • Disseminated Intravascular Coagulation (drug therapy, etiology)
  • Fluorouracil (administration & dosage, therapeutic use)
  • Humans
  • Male
  • Methotrexate (administration & dosage, therapeutic use)
  • Neoplasm Recurrence, Local (complications, drug therapy)
  • Stomach Neoplasms (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: